Patent ID: 9682146
Date: 2017-06-20
CPC Classifications: A61F,A61H,A61K,A61N,A61P

Claim:
1. A method for treating cancer in a subject in need thereof, the method comprising: administering to the subject a pharmaceutical agent comprising at least one of 8-methoxypsoralen (8-MOP) and 4′-aminomethyl-4,5′,8-trimethylpsoralen (AMT) that causes an auto-vaccine effect when activated; administering to the subject at least one energy modulation agent comprising a phosphorescent, fluorescent, or luminescent agent that, upon reception of an initiation energy, emits light that activates the pharmaceutical agent; and applying the initiation energy from an energy source to the subject, wherein the initiation energy is X-ray energy, wherein the at least one energy modulation agent activates the pharmaceutical agent in situ with said light emitted from the phosphorescent, fluorescent, or luminescent agent, thus causing an auto-vaccine effect, wherein the auto-vaccine effect occurs in vivo in the subject in need, and wherein said auto-vaccine effect treats cancer, and wherein the pharmaceutical agent is activated by one or more sequential single photon absorption events.